Skip to main content

Multiple Myeloma

Featured Article
Deepu Madduri, MD, assistant professor, Hematology and Medical Oncology of the Mount Sinai Hospital, Mount Sinai Beth Israel, discusses the results of the CARTITUDE-1 study, which analyzed …
Ravi Vij, MD, MBA, from Washington University School of Medicine in St Louis, discusses his recent study findings that evaluated treatment sequences among patients with relapsed or refractory…

Insights

Alfred L Garfall, MD, MS, assistant professor of Medicine, Perelman School of Medicine, University of Pennsylvania, discusses his recent study presented at ASH 2020, which examined the use of teclistamab for the treatment of multiple myeloma,…
Deepu Madduri, MD, assistant professor, Hematology and Medical Oncology of the Mount Sinai Hospital, Mount Sinai Beth Israel, discusses the results of the CARTITUDE-1 study, which analyzed ciltacabtagene autoleucel, a CAR-T-cell therapy with 2 B-…
Ravi Vij, MD, MBA, from Washington University School of Medicine in St Louis, discusses his recent study findings that evaluated treatment sequences among patients with relapsed or refractory multiple myeloma after failure of daratumumab-based…
Back to Top